<?xml version="1.0" encoding="UTF-8"?>
<p id="Par21">Enterovirus A71 (EV-A71) has caused various symptoms and diseases ranging from hand-foot-and-mouth disease (HFMD), herpangina, rashes, and diarrhea, to aseptic meningitis, pulmonary edema, acute flaccid paralysis (AFP), brainstem encephalitis and Guillain–Barré syndrome [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR2">2</xref>]. Although EV-A71 infections are often asymptomatic, severe symptoms can also result in neurological disease and even death [
 <xref ref-type="bibr" rid="CR2">2</xref>]. Following the first EV-A71 identified in 1969, EV-A71 has been circulating in the Asia-Pacific region such as Japan in the 1970s [
 <xref ref-type="bibr" rid="CR3">3</xref>], Asia in the 1980s [
 <xref ref-type="bibr" rid="CR4">4</xref>], and Malaysia and Taiwan in the 1990s [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR5">5</xref>–
 <xref ref-type="bibr" rid="CR8">8</xref>]. Since the 1990s, large-scale epidemics have been observed [
 <xref ref-type="bibr" rid="CR9">9</xref>]. Since then, EV-A71 infections have caused mortality rates ranging from &lt; 0.5–19% in Asia-Pacific countries [
 <xref ref-type="bibr" rid="CR1">1</xref>, 
 <xref ref-type="bibr" rid="CR10">10</xref>–
 <xref ref-type="bibr" rid="CR14">14</xref>].
</p>
